首页> 外文期刊>Indian heart journal >Challenges to establish causality between hypertensive retinopathy and Grade III hypertension: A retrospective cohort analysis
【24h】

Challenges to establish causality between hypertensive retinopathy and Grade III hypertension: A retrospective cohort analysis

机译:建立高血压视网膜病变与III级高血压之间因果关系的挑战:回顾性队列分析

获取原文
           

摘要

Background: Accelerated/Malignant hypertension (A/MH) is ahypertensive emergency, clinically defined by the European societyof Hypertension/European society of cardiology (ESH/ESC) asthe presence of very high BP associated with target organ damage(TOD) [retina, kidney, heart or brain]. The 5 years survival ratereported after the diagnosis of A/MH has improved significantlywhich could be due to earlier diagnosis, lower BP targets andavailability of new classes of antihypertensive agents.Objective: To estimate the incidence of A/MH and evaluate itsprognosis and management.Methods: A retrospective cohort analysis was carried out at our2500 bedded tertiary care teaching hospital on patients admittedwith essential HTN (during 2008 - 2012) with ICD e 10 (I.10) codingwith no comorbidities with age 40 were considered for the study.Results: Of the 305 in-patients diagnosed with essential HTN, 17(5.8%) were found to have Grade III HTN (ESH/ESC 2013) whichwere documented as A/MH. Male predominance was found to behigher with 53% with a mean age for 58 years (±10 SD) and meanBMI of 23.8 (±4.7 SD). TOD identified in 17 patients were: 2 patients(12%) ophthalmic, 9 (53%) left ventricular failure and none reportedin 6 (35%). All patients except one were treated withamlodipine (88%) either as monotherapy or with other classesincluding ARBs, ACEi, diuretics, beta blockers or clonidine. Readmissionswere reported in 5 (29%) with only 1(6%) being diagnosedwith CAD on the first readmission.Conclusion: Going by the standard criteria for diagnosing A/MHwhere BP is 180/ 110, through our study we could safely concludethat 14 patients (83%) were either not reported with visualchanges or not being referred for ophthalmic evaluation. Thiscould also.
机译:背景:加速/恶性高血压(A / MH)是高血压急症,由欧洲高血压学会/欧洲心脏病学会(ESH / ESC)在临床上定义为存在与靶器官损害(TOD)相关的极高BP [视网膜,肾脏,心脏或大脑]。 A / MH诊断后报告的5年生存率显着提高,这可能是由于早期诊断,降低BP靶点和新型降压药的有效性。目的:评估A / MH的发生率并评估其预后和治疗方法。 :我们在2500床的三级护理教学医院对包括ICD e 10(I.10)编码且没有40岁合并症的基本HTN入院(2008年至2012年)的患者进行了回顾性队列分析。在305名被诊断患有基本HTN的住院患者中,有17名(5.8%)被发现为III级HTN(ESH / ESC 2013),其记录为A / MH。发现男性优势较高,平均年龄为58岁(±10 SD)和平均BMI为23.8(±4.7 SD)的男性占53%。在17例患者中确定的TOD为:2例眼科患者(12%),左心衰竭9例(53%),6例中无报道(35%)。除一名患者外,所有患者均接受氨氯地平(88%)单一疗法或其他类别的药物治疗,包括ARB,ACEi,利尿剂,β受体阻滞剂或可乐定。报告的再入院率为5(29%),首次再入院时诊断为CAD的率为1(6%)。结论:按照诊断BP为180/110的A / MH的标准标准,通过我们的研究,我们可以安全地得出结论:14例患者(83%)未报告视力改变或未转介进行眼科评估。这也可以。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号